What's Next For Vaccines For Kids 5 To 11 After Pfizer Releases New Trial Data
As pediatric cases of COVID-19 continue to rise in the U.S., we’re now one step closer to getting children under 12 vaccinated.
Pfizer BioNTech released the first batch of data from trials for kids 5 to 11 on Monday, showing that its vaccine is effective and safe for that age group. It may still be a while though before these younger children, who are currently not eligible to be vaccinated, actually get shots in arms.
Here & Now‘s Robin Young speaks with Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital and dean of the National School of Tropical Medicine at Baylor College of Medicine.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.